Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CRAI
  4. CRA International, Inc. (CRAI) Q1 2026 Earnings Call Transcript

CRA International, Inc. (CRAI) Q1 2026 Earnings Call Transcript

CRAI logo
CRAI
CRA International Inc
152.98 USD
-1.54%

Access earnings results, analyst expectations, report, slides, earnings call, and transcript.

Overview

The earnings call reflects strong financial performance with record revenue and profitability, particularly in the Life Sciences and M&A sectors. Although there are increased costs and a restructuring charge, the company maintains a positive outlook with strong demand and utilization rates. The Q&A reveals optimism about talent acquisition and growth despite some general responses. Given the market cap, this translates to a positive stock price movement, likely between 2% to 8%.

Key Financial Performance

Revenue $201 million, a 10.5% increase year-over-year. This represents the highest quarterly revenue in the company's history, driven by broad-based contributions with 8 practices growing year-over-year. Specific practices like Energy, Finance, Forensic Services, and Life Sciences posted double-digit revenue growth.

North American Operations Revenue Increased by 8.5% year-over-year, driven by broad-based contributions.

International Operations Revenue Expanded by 20.3% year-over-year, reflecting strong performance across geographies.

Consultant Headcount Increased by 2.5% year-over-year to 971, supported by replenishing of the sales pipeline and increased project originations.

Consultant Utilization Improved to 77% year-over-year, supported by increased project lead flow and new project originations.

Non-GAAP EBITDA $23.2 million, representing 11.5% of revenue. This was affected by higher employee-related benefit costs and taxes due to annual bonuses. Noncash amortization of forgivable loans increased by $4.8 million or 53% year-over-year.

Legal and Regulatory Services Revenue Increased by 11.5% year-over-year, in line with broader legal market growth.

Worldwide M&A Activity Totaled $1.2 trillion, a 27% increase year-over-year, marking the strongest opening quarter for dealmaking since 2021.

Restructuring Charge $2.6 million, affecting 22 individuals across various practices and departments. This includes $1.6 million in cash charges and $1.0 million in noncash charges, with anticipated annual cost savings of approximately $5 million.

Capital Deployment Net cash outlays of $62.3 million for talent investments, including senior talent acquisition, performance awards, and talent retention. $25.3 million returned to shareholders through dividends and share repurchases.

Cash and Borrowings $32.5 million in cash and $192 million in borrowings under the revolving credit facility, resulting in net debt of $159.5 million. Borrowings were elevated to fund annual bonus payments.

Liquidity $86.7 million, consisting of $32.5 million in cash and $54.2 million of available capacity on the line of credit.

Credit Facility Increased by $50 million to $300 million of aggregate borrowing capacity to support growth and working capital needs.

You have reached the limit. Sign up to access full content
Get started

Operating Highlights

Antitrust & Competition Economics practice: Delivered a record quarter, capitalizing on ongoing merger-related activity and continued demand for antitrust services. Supported major mergers and defended against damages claims in high-profile cases.

Energy practice: Supported a wide array of clients, including utilities, electric system operators, and private equity. Advised on data center tariffs, load management, and regulatory due diligence for solar portfolios.

Life Sciences practice: Developed strategies for pharmaceutical companies, including pricing and market access for new therapies. Conducted global pricing studies for combination therapies in cardiovascular and nephrology markets.

Geographic expansion: North American operations increased revenue by 8.5%, while international operations expanded by 20.3% year-over-year.

M&A market: Worldwide M&A activity totaled $1.2 trillion in Q1 2026, up 27% year-over-year. CRA's Antitrust & Competition Economics practice capitalized on this growth.

Consultant headcount and utilization: Consultant headcount increased by 2.5% year-over-year, and utilization improved to 77%.

Restructuring efforts: Reconfigured consulting teams, affecting 22 individuals, resulting in a $2.6 million restructuring charge but anticipated annual cost savings of $5 million.

AI integration: Positioned AI as a demand amplifier and productivity enhancer, emphasizing its role in enhancing CRA's expertise and credibility.

Capital deployment: Invested $62.3 million in talent acquisition and retention, and expanded credit facility by $50 million to support growth.

You have reached the limit. Sign up to access full content
Get started

Risk or Challenges

Economic and Geopolitical Conditions: The company acknowledges that evolving geopolitical, global macroeconomic, and business conditions could impact its operations and financial performance.

Restructuring and Talent Optimization: The company undertook restructuring efforts affecting 22 individuals across various practices and departments, incurring a $2.6 million charge. While annual cost savings are expected, there is a risk of disruption or reduced efficiency during the transition.

Credit Facility and Debt Levels: The company increased its credit facility by $50 million to support growth and working capital needs, but elevated borrowings and net debt of $159.5 million could pose financial risks if not managed effectively.

Employee-Related Costs: The first quarter is disproportionately affected by higher employee-related benefit costs and taxes due to annual bonus payments, which could strain cash flow.

Regulatory and Legal Risks: The company is involved in complex legal and regulatory projects, including antitrust and privacy class actions, which could expose it to reputational and financial risks if outcomes are unfavorable.

Market Misunderstanding of Business Model: Management expressed concerns about a fundamental misunderstanding of the company's business model in the market, which could affect investor confidence and stock performance.

You have reached the limit. Sign up to access full content
Get started

Guidance & Outlook

Full Year Financial Guidance for Fiscal 2026: The company reaffirmed its full-year financial guidance for fiscal 2026, citing a strong start to the year, supportive market trends, and a robust sales pipeline. However, management remains cautious about potential impacts from evolving geopolitical, global macroeconomic, and business conditions.

Talent Investments and Cost Optimization: The company plans to redeploy annual cost savings of approximately $5 million from recent restructuring efforts back into the business to strengthen operations and pursue profitable growth in the coming quarters.

Credit Facility Expansion: The company increased its credit facility by $50 million, bringing the total borrowing capacity to $300 million. This expansion is intended to provide financial flexibility to support continued growth and working capital needs as annual revenues approach $800 million.

AI's Impact on Business: Management views AI as both a demand amplifier and productivity enhancer, strengthening the company's position due to its deep expertise, strong governance, and established credibility. AI is expected to enhance, but not replace, the company's expert judgment and capabilities in complex and high-stakes environments.

You have reached the limit. Sign up to access full content
Get started

Shareholder Return Plan

Dividend Payments: $3.8 million of dividend payments were made during the first quarter of 2026.

Share Repurchase: $21.5 million was spent on repurchasing approximately 116,000 shares during the first quarter of 2026.

Remaining Share Repurchase Program: $44.5 million is still available under the share repurchase program.

You have reached the limit. Sign up to access full content
Get started

Key Q&A

Q:What is driving the strong demand environment for the company?
A:Paul Maleh attributed the strong demand environment to a combination of factors, including the quality of the company's services and colleagues, record highs in revenue and profitability, and the increasing complexity of the world requiring expertise. He noted that 98% of the revenue from their 8 practices grew year-over-year by over 10%.
Q:What is contributing to the growth in the Life Sciences practice?
A:Paul Maleh highlighted that the Life Sciences practice has shown multiple quarters of substantive growth, including double-digit growth this year. European operations grew more than 20%, driven by the Life Sciences and Antitrust & Competition Economics practices. The lead flow for the practice is robust, and they are converting opportunities effectively.
Q:How does the company factor acquisition talent and related costs into its 2026 guidance?
A:Paul Maleh explained that the revenue guidance does not include anticipated inorganic revenue additions due to uncertainty in timing and ramp-up of new hires. However, the profitability margin guidance includes acquisition costs and related amortization.
Q:What is the company's approach to assignment changes and recruitment?
A:Paul Maleh emphasized the company's focus on recruiting the best available talent across its 8 practices, which are delivering top-line growth. He noted that the individuals hired in fiscal 2025 are performing ahead of expectations in 2026, and recruitment efforts are ongoing in both legal-regulatory and management consulting areas.
Q:How has utilization improved, and what is the outlook?
A:Utilization has been strong, at the upper 70% mark, starting in January 2026. This improvement was observed across both legal-regulatory and management consulting areas, contributing to top-line growth. The company aims to maintain this level of utilization going forward.
Q:What changes have been observed in the complexity of M&A and other practices?
A:Paul Maleh noted that the complexity of M&A and other practices has increased, with more data to analyze, broader and more complex markets, and higher demand for expeditious results. This trend is observed across all business units, including Antitrust Competition Economics, Life Sciences, and Energy practices.
Q:What is the company's approach to rate realization and pricing?
A:The company implemented low to mid-single-digit rate increases at the beginning of the year. These increases are more likely to benefit new projects rather than legacy ones. Early indications of the rate increases are positive, with no significant increase in write-offs, and the company expects more contribution from these increases in Q2 and Q3.
Q:Review of Unclear Management Responses
A:Paul Maleh avoided providing specific details about the macro environment driving demand, stating that it is a combination of factors and the world becoming more complex. Additionally, he provided generalities rather than specifics when discussing the complexity of M&A and other practices, citing his lack of recent direct involvement in cases.
You have reached the limit. Sign up to access full content
Get started

Earnings Word Cloud

The most frequently occurring keywords in this quarter's earning call
AI
Antitrust Competition
CRA competition
Competition Economics
ECL
Economics practice
Energy
Executive VP
Life Sciences
Patent Court
REEL
Sciences practice
advertising technology
bonus
build
capacity
charge
claim
code
credibility
credit facility
dispute
equity
food
governance
noncash
opportunity talent
policy
pricing
privacy
project CRA
replenishing sale
saving
software development
system
transaction
trial

CRAI Transcript

CRA International, Inc. (CRAI) Q1 2026 Earnings Call Transcript
Positive5-9

The earnings call reflects strong financial performance with record revenue and profitability, particularly in the Life Sciences and M&A sectors. Although there are increased costs and a restructuring charge, the company maintains a positive outlook with strong demand and utilization rates. The Q&A reveals optimism about talent acquisition and growth despite some general responses. Given the market cap, this translates to a positive stock price movement, likely between 2% to 8%.

CRA International, Inc. (CRAI) Q4 2025 Earnings Call Transcript
Positive2-26

The earnings call reveals record-high revenue and strong performance across various practices, with optimistic guidance for fiscal 2026. The Q&A section supports this with positive sentiment towards revenue growth, AI initiatives, and shareholder returns. Despite flat headcount growth, future increases are expected, aligning with revenue growth. The company's active share repurchase plan indicates confidence in undervaluation. Overall, strong financial metrics, optimistic guidance, and strategic initiatives suggest a positive stock price movement.

CRA International, Inc. (CRAI) Presents at UBS Global Technology and AI Conference 2025 Transcript
Neutral12-1
CRA International, Inc. (CRAI) Q3 2025 Earnings Call Transcript
Positive10-30

The earnings call summary and Q&A indicate strong financial performance, optimistic guidance, and strategic growth in key areas like energy and life sciences. The increase in dividends and share repurchases is a positive indicator for shareholder returns. Although there are concerns about headcount and long-term visibility, these are outweighed by positive growth metrics and strategic positioning. Given the market cap of $1.2 billion, the stock is likely to experience a positive movement of 2% to 8% over the next two weeks.

CRAI Slides

PDFCRA International Q1 2026 slides: record revenue, EPS pressures
2026-05-07
PDFCRA International FY2025 slides: 9% growth, strong margins, AI opportunity
2026-02-26

CRAI Report

CRA INTERNATIONAL, INC. 10-K
10-K
2025-02-20
CRA INTERNATIONAL, INC. 10-Q
10-Q
2024-10-31
CRA INTERNATIONAL, INC. 10-Q
10-Q
2024-05-02
CRA INTERNATIONAL, INC. 10-K
10-K
2024-02-29

Frequently Asked Questions

Where does this earnings call transcript come from?

All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.

How soon is the transcript available after the earnings call ends?

Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.

Is the transcript edited or altered in any way?

No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.

Why do some answers appear as “Unclear” or “Inaudible”?

When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.

Who creates the AI Summary and Key Q&A highlights shown above the transcript?

They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.

Explore More Earnings

PENG logo
PENG
2026-07-07 16:05:00
after hour
After Hours
Revenue
$478.71M
+10.05%
EPS
-$0.71
+12.70%
AI Prediction
-
AI Summary
Calendar ReportReport
KRUS logo
KRUS
2026-07-07 16:06:00
after hour
After Hours
Revenue
$85.92M
-0.40%
EPS
-$0.03
+160.00%
AI Prediction
-
AI Summary
Calendar ReportReport
SAR logo
SAR
2026-07-07 16:24:00
after hour
After Hours
Revenue
$30.78M
-2.82%
EPS
-$0.47
-12.96%
AI Prediction
-
Calendar ReportReport
EPAC logo
EPAC
2026-07-07 17:04:00
after hour
After Hours
Revenue
$167.55M
+1.86%
EPS
-$0.60
+22.45%
AI Prediction
-
Calendar ReportReport
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia